Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbation.

Li WB, Zhu J, Hart B, Sui B, Weng K, Chang S, Geiger R, Torremorell M, Mileham A, Gladney C, Mellancamp MA, Li L, Yunus A, Goldblatt M, Kinch MS.

Am J Transl Res. 2009 Apr 12;1(3):259-66.

2.

The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza.

Sui B, Bamba D, Weng K, Ung H, Chang S, Van Dyke J, Goldblatt M, Duan R, Kinch MS, Li WB.

Virology. 2009 May 10;387(2):473-81. doi: 10.1016/j.virol.2009.02.046. Epub 2009 Mar 27.

3.

Identification of novel host-oriented targets for Human Immunodeficiency Virus type 1 using Random Homozygous Gene Perturbation.

Mao H, Chen H, Fesseha Z, Chang S, Ung-Medoff H, Van Dyke J, Kohli M, Li WB, Goldblatt M, Kinch MS.

Virol J. 2009 Sep 29;6:154. doi: 10.1186/1743-422X-6-154.

5.

Identification of annexin A13 as a regulator of chemotherapy resistance using random homozygous gene perturbation.

Reiske H, Sui B, Ung-Medoff H, Donahue R, Li WB, Goldblatt M, Li L, Kinch MS.

Anal Quant Cytol Histol. 2010 Apr;32(2):61-9.

PMID:
20701074
6.

Gene expression signature-based screening identifies new broadly effective influenza a antivirals.

Josset L, Textoris J, Loriod B, Ferraris O, Moules V, Lina B, N'guyen C, Diaz JJ, Rosa-Calatrava M.

PLoS One. 2010 Oct 4;5(10). pii: e13169. doi: 10.1371/journal.pone.0013169.

7.

Achieving clinical equality in an influenza pandemic: patent realities.

Kane EM.

Seton Hall Law Rev. 2009;39(4):1137-72.

PMID:
20718133
8.

Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.

Tsukamoto M, Hiroi S, Adachi K, Kato H, Inai M, Konishi I, Tanaka M, Yamamoto R, Sawa M, Handharyani E, Tsukamoto Y.

Mol Med Rep. 2011 Mar-Apr;4(2):209-14. doi: 10.3892/mmr.2011.410. Epub 2011 Jan 3.

PMID:
21468553
9.

Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.

Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, Jagger BW, Chertow DS, Li Q, Kuestner RE, Ozinsky A, Taubenberger JK.

MBio. 2011 Sep 20;2(5). pii: e00172-11. doi: 10.1128/mBio.00172-11. Print 2011.

10.

Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

Krammer F, Palese P, Steel J.

Curr Top Microbiol Immunol. 2015;386:301-21. doi: 10.1007/82_2014_408. Review.

PMID:
25007847
12.

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.

Ng S, Wu P, Nishiura H, Ip DK, Lee ES, Cowling BJ.

BMC Infect Dis. 2011 Aug 26;11:230. doi: 10.1186/1471-2334-11-230.

13.

Identification of hepatic microvascular adhesion-related genes of human colon cancer cells using random homozygous gene perturbation.

Márquez J, Kohli M, Arteta B, Chang S, Li WB, Goldblatt M, Vidal-Vanaclocha F.

Int J Cancer. 2013 Nov;133(9):2113-22. doi: 10.1002/ijc.28232. Epub 2013 Jun 29.

14.

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

Wohlbold TJ, Nachbagauer R, Xu H, Tan GS, Hirsh A, Brokstad KA, Cox RJ, Palese P, Krammer F.

MBio. 2015 Mar 10;6(2):e02556. doi: 10.1128/mBio.02556-14.

15.

Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus.

Lam WY, Leung TF, Lee N, Cheung JL, Yeung AC, Ho YI, Chan RC, Fung KS, Barr IG, Hui DS, Sung JJ, Chan PK.

J Med Virol. 2010 Apr;82(4):675-83. doi: 10.1002/jmv.21725.

PMID:
20166184
16.

Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.

Bragstad K, Martel CJ, Thomsen JS, Jensen KL, Nielsen LP, Aasted B, Fomsgaard A.

Influenza Other Respir Viruses. 2011 Jan;5(1):13-23. doi: 10.1111/j.1750-2659.2010.00177.x. Epub 2010 Nov 3.

17.

Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection.

Nelson CA, France EK, Shetterly SM, Glanz JM.

Pediatr Infect Dis J. 2011 Jul;30(7):562-5. doi: 10.1097/INF.0b013e31820bb482.

PMID:
21248657
18.

H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice.

Morrison J, Josset L, Tchitchek N, Chang J, Belser JA, Swayne DE, Pantin-Jackwood MJ, Tumpey TM, Katze MG.

J Virol. 2014 Sep;88(18):10556-68. doi: 10.1128/JVI.00570-14. Epub 2014 Jul 2.

19.

Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection.

Imai Y.

Biochim Biophys Acta. 2015 Apr;1851(4):496-502. doi: 10.1016/j.bbalip.2015.01.006. Epub 2015 Jan 22. Review.

PMID:
25617737
20.

Establishment of a UK National Influenza H5 Laboratory Network.

Curran MD, Ellis JS, Wreghitt TG, Zambon MC.

J Med Microbiol. 2007 Oct;56(Pt 10):1263-7. Review.

PMID:
17893159

Supplemental Content

Support Center